Blumenthal-Barby J S, Robinson Emily, Cantor Scott B, Naik Aanand D, Russell Heidi Voelker, Volk Robert J
Department of Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas (JSB-B)
Department of Organizational Behavior, INSEAD, Fontainebleau, France (ER)
Med Decis Making. 2015 May;35(4):412-8. doi: 10.1177/0272989X14564433. Epub 2015 Jan 12.
Costs are an important component of patients' decision making, but a comparatively underemphasized aspect of formal shared decision making. We hypothesized that decision aids also avoid discussion of costs, despite their being tools designed to facilitate shared decision making about patient-centered outcomes. We sought to define the frequency of cost-related information and identify the common modes of presenting cost and cost-related information in the 290 decision aids catalogued in the Ottawa Hospital Research Institute's Decision Aid Library Inventory (DALI) system. We found that 56% (n = 161) of the decision aids mentioned cost in some way, but only 13% (n = 37) gave a specific price or range of prices. We identified 9 different ways in which cost was mentioned. The most common approach was as a "pro" of one of the treatment options (e.g., "you avoid the cost of medication"). Of the 37 decision aids that gave specific prices or ranges of prices for treatment options, only 2 were about surgery decisions despite the fact that surgery decision aids were the most common. Our findings suggest that presentation of cost information in decision aids is highly variable. Evidence-based guidelines should be developed by the International Patient Decision Aid Standards (IPDAS) Collaboration.
成本是患者决策的一个重要组成部分,但在正式的共同决策中是一个相对被忽视的方面。我们假设决策辅助工具也会避免讨论成本,尽管它们是旨在促进围绕以患者为中心的结果进行共同决策的工具。我们试图确定与成本相关信息的出现频率,并识别渥太华医院研究所决策辅助工具库清单(DALI)系统中编目的290种决策辅助工具中呈现成本及与成本相关信息的常见方式。我们发现,56%(n = 161)的决策辅助工具以某种方式提及了成本,但只有13%(n = 37)给出了具体价格或价格范围。我们确定了提及成本的9种不同方式。最常见的方法是将成本作为其中一种治疗选择的“优点”(例如,“你避免了药物治疗的成本”)。在为治疗选择给出具体价格或价格范围的37种决策辅助工具中,尽管手术决策辅助工具是最常见的,但只有2种是关于手术决策的。我们的研究结果表明,决策辅助工具中成本信息的呈现方式差异很大。国际患者决策辅助标准(IPDAS)协作组织应制定基于证据的指南。